Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sarepta Therapeutics (SRPT) Q4 2024 Earnings Call Transcript


Image source: The Motley Fool.

Sarepta Therapeutics (NASDAQ: SRPT)
Q4 2024 Earnings Call
Feb 26, 2025, 4:30 p.m. ET

Operator

Continue reading


Source Fool.com

Sarepta Therapeutics Stock

€15.80
-8.410%
Sarepta Therapeutics took a tumble today and lost -€1.450 (-8.410%).
The community is currently still undecided about Sarepta Therapeutics with 2 Buy predictions and 0 Sell predictions.
With a target price of 135 € there is potential for a 754.43% increase which would mean more than doubling the current price of 15.8 € for Sarepta Therapeutics.
Like: 0
Share

Comments